𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Value of Sentinel Lymph Node Biopsy in Breast Ductal Carcinoma in Situ Upstaged to Invasive Carcinoma

✍ Scribed by Rita Sakr; Martine Antoine; Emmanuel Barranger; Gil Dubernard; Christine Salem; Emile Daraï; Serge Uzan

Book ID
109079614
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
72 KB
Volume
14
Category
Article
ISSN
1075-122X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sentinel lymph node biopsy in patients w
Sentinel lymph node biopsy in patients with ductal carcinoma in situ : A proposal
✍ Kelly M. McMasters; Celia Chao; Sandra L. Wong; Robert C. G. Martin III; Michael 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 1 views

Sentinel lymph node (SLN) biopsy for the treatment of ductal carcinoma in situ (DCIS) is not necessary and generally should be limited to those patients with a core needle biopsy diagnosis of DCIS who are undergoing mastectomy. Used in this way, SLN biopsy will spare the majority of patients with oc

Occult “micrometastases” in ductal carci
Occult “micrometastases” in ductal carcinoma in situ : Investigative implications for sentinel lymph node biopsy.
✍ Donald L. Weaver 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

Sentinel lymph node biopsy is frequently associated with identification of micrometastatic tumor deposits. The clinical relevance of identifying micrometastases in breast cancer must be evaluated in the statistical context of the lymph node evaluation strategy and the likelihood of missing a metasta